NuCana

NCNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.32

-$0.02 (-1.49%)

At close: Sep 21, 2026, 4:00 PM ET

$1.32

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.49%

(1D)

Rating

Updated: Sep 19, 2026

11.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $8.02M

1D Range

1.32 1.37

52W Range

1.21 7.22

Valuation (TTM)

PE -0.39

PB 0.30

EV/EBITDA 0.88

Valuation (NTM)

Forward PE N/A

Forward PEG -0.00

Price Target N/A

Cash Flow

FCF Yield -86.0%

SBC Adj. FCF Yield -147.1%

SBC Impact -71.2%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 4.3% | -36.0%

FCF 3Y | 5Y 44.0% | 27.1%

Returns

ROA -38.0%

ROE -42.0%

ROIC -56.6%

Financial Health

Net Cash

£19.35M ($25.65M)

Current Ratio 4.73

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platfo...

Sector Healthcare

Industry Biotechnology

Employees 11

IPO Date Sep 27, 2017

Website www.nucana.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.